Not only for culprit drug identification, currently, a rapid immunochromatographic test for serum granulysin has exhibited predictability in the early stage of SJS/TEN 2–4 days prior to typical mucosal and cutaneous symptoms, revealing a usefulness of granulysin in the early diagnosis of SCARs. This evidence concerns the gene GNLY and toxic epidermal necrolysis.